NEW DELHI: In a pandemic situation, emergency use of vaccinations is considered based on safety and immunogenicity data while phase three clinical trial It is underway, the head of the Indian Council for Medical Research (ICMR), Balram Bhargava, said on Tuesday. Explaining the process followed to grant approval to the …
Read More »
NEW DELHI: With three anti-Covid vaccines under regulatory review for emergency use, the government is preparing 28,947 cold chain points with 85,643 pieces of equipment across the country that are capable of storing the vaccines needed for the first set than 3 crore of health and frontline workers. The Center …
Read More »
NEW DELHI: The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the citing unmet medical needs due to the pandemic and in the …
Read More »
NEW DELHI: Prime Minister Narendra Modi will embark on a three-city visit on Saturday to personally review the vaccine development and manufacturing process. He will visit the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and the Serum Institute of India in Pune, Maharashtra, the Prime Minister’s Office said. …
Read More »
LONDON / MANILA: Britain asked its regulator on Friday to evaluate AstraZeneca’s Covid-19 vaccine for a possible launch, while the Philippines and Thailand secured millions of doses, giving the injection a vote of confidence after it the experts raised questions about test data. The UK government, which has secured 100 …
Read More »
NEW DELHI: India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidates, which the firm says is 62% effective and not the “more complete half” dose regimen, which is claimed to be up to 90% effective, but has drawn criticism for dosing errors. the Indian governmentThe …
Read More »
NEW DELHI: An estimated one crore of front-line healthcare workers will receive the first dose of the Covid-19 vaccine when it becomes available, with about 92 percent of government hospitals and 55 percent of private hospitals in all states and UT providing data that identifies workers. , said official sources. …
Read More »
FRANKFURT: Moderna will charge governments between $ 25 and $ 37 per dose of its Covid-19 candidate vaccine, depending on the amount requested, Chief Executive Stephane Bancel told the German weekly Welt am Sonntag (WamS). “So our vaccine costs about the same as a flu shot, which is between $ …
Read More »
Pfizer Inc and BioNTech Could Obtain Emergency Clearance in US and Europe for Their Covid-19 vaccine the next month, after the final results of the trial showed it had a 95% success rate and no serious side effects, drug makers said Wednesday. The efficacy of the vaccine was found to …
Read More »
Moderna Inc said Monday that its experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from an advanced-stage clinical trial, becoming the second American company in a week to report results that far exceed expectations. Along with the Pfizer Inc vaccine, which has also been shown to …
Read More »